Top Markets
Coin of the day
Tectonic Therapeutic, Inc. Tectonic Therapeutic, Inc.

Tectonic Therapeutic, Inc.

TECX
Clasificación en acciones #11671
Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm... Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the discovery and development of these GPCR-targeted medicines. Its robust pipeline includes an RXFP1 agonist, currently undergoing Phase 1a and 1b clinical trials for the treatment of heart failure with preserved ejection fraction. Additional programs encompass a GPCR antagonist addressing hereditary hemorrhagic telangiectasia, a bi-functional GPCR modulator aimed at fibrosis, and various other GPCR modulators. Tectonic Therapeutic, Inc. is situated in Watertown, Massachusetts.
Precio por acción
$35.63
Última sincronización: 2026-08-28
Capitalización bursátil
$672.28M
Cambio (1 día)
-2.92%
Cambio (1 año)
39.50%
País
US
Comercio Tectonic Therapeutic, Inc. (TECX)

Categoría

Ratio P/S de Tectonic Therapeutic, Inc. (TECX)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Tectonic Therapeutic, Inc., el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Tectonic Therapeutic, Inc. desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
10.17 -
US
10.13 -
NL
2.95 -
AU
11.28 -
US
- -
CH